Announcements
- Significant POLB 001 Patent Granted in USA
- Appointment of Joint Broker
- Option Agreement to Acquire Orphan Drug Candidate
- Results for the year ended 31 December 2023
- TR-1: Notification of major holdings
- POLB 001 US Patent Update
- Director/PDMR Shareholding
- Director Share Purchase
- Board Role Change and Launch of EIP
- Market Opportunity for POLB 001 for CRS
More ▼
Key statistics
On Friday, Poolbeg Pharma PLC (7JN:FRA) closed at 0.137, -2.14% below its 52-week high of 0.14, set on May 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.137 |
---|---|
High | 0.137 |
Low | 0.137 |
Bid | 0.144 |
Offer | 0.167 |
Previous close | 0.14 |
Average volume | 0.00 |
---|---|
Shares outstanding | 500.00m |
Free float | 386.69m |
P/E (TTM) | -- |
Market cap | 66.75m GBP |
EPS (TTM) | -0.0079 GBP |
Data delayed at least 15 minutes, as of May 03 2024 07:06 BST.
More ▼